The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Stromal Vascular Fraction-Global Market Insights and Sales Trends 2024
Synopsis
Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body.
The global Stromal Vascular Fraction market size is expected to reach US$ 102.5 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Stromal Vascular Fraction in various end use industries. The expanding demands from the Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Others, are propelling Stromal Vascular Fraction market. SVF Isolation Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymatic Isolation segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stromal Vascular Fraction, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stromal Vascular Fraction market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stromal Vascular Fraction market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stromal Vascular Fraction sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stromal Vascular Fraction covered in this report include Cytori Therapeutics, GE Healthcare, Ingeneron, Medikan International, Tissue Genesis, Genesis Biosystems, Human Med, IntelliCell BioSciences and LifeCell, etc.
The global Stromal Vascular Fraction market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cytori Therapeutics
GE Healthcare
Ingeneron
Medikan International
Tissue Genesis
Genesis Biosystems
Human Med
IntelliCell BioSciences
LifeCell
Global Stromal Vascular Fraction market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stromal Vascular Fraction market, Segment by Type:
SVF Isolation Products
Enzymatic Isolation
Non-enzymatic Isolation
Automated POC Devices
SVF Aspirate Purification Products
SVF Transfer Products
Global Stromal Vascular Fraction market, by Application
Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stromal Vascular Fraction companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body.
The global Stromal Vascular Fraction market size is expected to reach US$ 102.5 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Stromal Vascular Fraction in various end use industries. The expanding demands from the Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Others, are propelling Stromal Vascular Fraction market. SVF Isolation Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymatic Isolation segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stromal Vascular Fraction, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stromal Vascular Fraction market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stromal Vascular Fraction market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stromal Vascular Fraction sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stromal Vascular Fraction covered in this report include Cytori Therapeutics, GE Healthcare, Ingeneron, Medikan International, Tissue Genesis, Genesis Biosystems, Human Med, IntelliCell BioSciences and LifeCell, etc.
The global Stromal Vascular Fraction market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cytori Therapeutics
GE Healthcare
Ingeneron
Medikan International
Tissue Genesis
Genesis Biosystems
Human Med
IntelliCell BioSciences
LifeCell
Global Stromal Vascular Fraction market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stromal Vascular Fraction market, Segment by Type:
SVF Isolation Products
Enzymatic Isolation
Non-enzymatic Isolation
Automated POC Devices
SVF Aspirate Purification Products
SVF Transfer Products
Global Stromal Vascular Fraction market, by Application
Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stromal Vascular Fraction companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Stromal Vascular Fraction
1.1 Stromal Vascular Fraction Market Overview
1.1.1 Stromal Vascular Fraction Product Scope
1.1.2 Stromal Vascular Fraction Market Status and Outlook
1.2 Global Stromal Vascular Fraction Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Stromal Vascular Fraction Market Size by Region (2018-2029)
1.4 Global Stromal Vascular Fraction Historic Market Size by Region (2018-2023)
1.5 Global Stromal Vascular Fraction Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Stromal Vascular Fraction Market Size (2018-2029)
1.6.1 North America Stromal Vascular Fraction Market Size (2018-2029)
1.6.2 Europe Stromal Vascular Fraction Market Size (2018-2029)
1.6.3 Asia-Pacific Stromal Vascular Fraction Market Size (2018-2029)
1.6.4 Latin America Stromal Vascular Fraction Market Size (2018-2029)
1.6.5 Middle East & Africa Stromal Vascular Fraction Market Size (2018-2029)
2 Stromal Vascular Fraction Market by Type
2.1 Introduction
2.1.1 SVF Isolation Products
2.1.2 Enzymatic Isolation
2.1.3 Non-enzymatic Isolation
2.1.4 Automated POC Devices
2.1.5 SVF Aspirate Purification Products
2.1.6 SVF Transfer Products
2.2 Global Stromal Vascular Fraction Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Stromal Vascular Fraction Historic Market Size by Type (2018-2023)
2.2.2 Global Stromal Vascular Fraction Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Stromal Vascular Fraction Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Stromal Vascular Fraction Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Stromal Vascular Fraction Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Stromal Vascular Fraction Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Stromal Vascular Fraction Revenue Breakdown by Type (2018-2029)
3 Stromal Vascular Fraction Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.1.3 Stem Cell Banks/Laboratories
3.1.4 Others
3.2 Global Stromal Vascular Fraction Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Stromal Vascular Fraction Historic Market Size by Application (2018-2023)
3.2.2 Global Stromal Vascular Fraction Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Stromal Vascular Fraction Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Stromal Vascular Fraction Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Stromal Vascular Fraction Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Stromal Vascular Fraction Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Stromal Vascular Fraction Revenue Breakdown by Application (2018-2029)
4 Stromal Vascular Fraction Competition Analysis by Players
4.1 Global Stromal Vascular Fraction Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Stromal Vascular Fraction as of 2022)
4.3 Date of Key Players Enter into Stromal Vascular Fraction Market
4.4 Global Top Players Stromal Vascular Fraction Headquarters and Area Served
4.5 Key Players Stromal Vascular Fraction Product Solution and Service
4.6 Competitive Status
4.6.1 Stromal Vascular Fraction Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cytori Therapeutics
5.1.1 Cytori Therapeutics Profile
5.1.2 Cytori Therapeutics Main Business
5.1.3 Cytori Therapeutics Stromal Vascular Fraction Products, Services and Solutions
5.1.4 Cytori Therapeutics Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.1.5 Cytori Therapeutics Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Stromal Vascular Fraction Products, Services and Solutions
5.2.4 GE Healthcare Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Ingeneron
5.3.1 Ingeneron Profile
5.3.2 Ingeneron Main Business
5.3.3 Ingeneron Stromal Vascular Fraction Products, Services and Solutions
5.3.4 Ingeneron Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.3.5 Medikan International Recent Developments
5.4 Medikan International
5.4.1 Medikan International Profile
5.4.2 Medikan International Main Business
5.4.3 Medikan International Stromal Vascular Fraction Products, Services and Solutions
5.4.4 Medikan International Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.4.5 Medikan International Recent Developments
5.5 Tissue Genesis
5.5.1 Tissue Genesis Profile
5.5.2 Tissue Genesis Main Business
5.5.3 Tissue Genesis Stromal Vascular Fraction Products, Services and Solutions
5.5.4 Tissue Genesis Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.5.5 Tissue Genesis Recent Developments
5.6 Genesis Biosystems
5.6.1 Genesis Biosystems Profile
5.6.2 Genesis Biosystems Main Business
5.6.3 Genesis Biosystems Stromal Vascular Fraction Products, Services and Solutions
5.6.4 Genesis Biosystems Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.6.5 Genesis Biosystems Recent Developments
5.7 Human Med
5.7.1 Human Med Profile
5.7.2 Human Med Main Business
5.7.3 Human Med Stromal Vascular Fraction Products, Services and Solutions
5.7.4 Human Med Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.7.5 Human Med Recent Developments
5.8 IntelliCell BioSciences
5.8.1 IntelliCell BioSciences Profile
5.8.2 IntelliCell BioSciences Main Business
5.8.3 IntelliCell BioSciences Stromal Vascular Fraction Products, Services and Solutions
5.8.4 IntelliCell BioSciences Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.8.5 IntelliCell BioSciences Recent Developments
5.9 LifeCell
5.9.1 LifeCell Profile
5.9.2 LifeCell Main Business
5.9.3 LifeCell Stromal Vascular Fraction Products, Services and Solutions
5.9.4 LifeCell Stromal Vascular Fraction Revenue (US$ Million) & (2018-2023)
5.9.5 LifeCell Recent Developments
6 North America
6.1 North America Stromal Vascular Fraction Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Stromal Vascular Fraction Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Stromal Vascular Fraction Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Stromal Vascular Fraction Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Stromal Vascular Fraction Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Stromal Vascular Fraction Market Dynamics
11.1 Stromal Vascular Fraction Industry Trends
11.2 Stromal Vascular Fraction Market Drivers
11.3 Stromal Vascular Fraction Market Challenges
11.4 Stromal Vascular Fraction Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
